Early initiation of prophylactic anticoagulation for prevention of COVID-19 mortality: a nationwide cohort study of hospitalized patients in the United States
Christopher T. Rentsch(University of London), Matthew S. Freiberg(Vanderbilt University), Walid F. Gellad(University of Pittsburgh), Suman Kundu(Emory University), Amy C. Justice(Yale University), Paul A. Heidenreich(Palo Alto University), Daniel Jacobson(Oak Ridge National Laboratory), Charles Alcorn(University of Pittsburgh), Stephen Evans(London School of Hygiene & Tropical Medicine), Melissa Skanderson(United States Department of Veterans Affairs), Svetlana Eden(Vanderbilt University Medical Center), Joseph T. King(United States Department of Veterans Affairs), Ian Douglas(London School of Hygiene & Tropical Medicine), P. Michael Ho(Chia-Yi Christian Hospital), Farah Kidwai‐Khan(United States Department of Veterans Affairs), Michael F Lann(University of Pittsburgh), Yuk‐Lam Ho(VA Boston Healthcare System), Robert A. Greevy(Vanderbilt University Medical Center), Laurie A. Tomlinson(London School of Hygiene & Tropical Medicine), Janet P. Tate(Yale University), Joshua A. Beckman(Clinical Research Institute), David Atkins(United States Department of Veterans Affairs), Evan L. Brittain(Vanderbilt University Medical Center)
Cited by 19
Related Papers
Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction
|Circulation|2010|4.8k
Forecasting the Future of Cardiovascular Disease in the United States
|Circulation|2011|3.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
Forecasting the Impact of Heart Failure in the United States
|Circulation Heart Failure|2013|2.8k